Author

David Holthaus

David Holthaus is an award-winning journalist and a Cincinnati native. When not writing or editing, he's likely to be bicycling, hiking, reading, or watching classic movies.

 

David Holthaus's Latest Articles

‘We can learn new perspectives’: Foundation exec changed her grantmaking approach after training

Racial Equity Matters workshops delivered a better understanding of how much of U.S. society has been built on racial foundations.

Eric DeWald
‘Eye-opening’ workshops generate a personal and professional impact for foundation leader

A history buff learned about the legacy of racism in the U.S. and made some changes.  

‘The change starts with me’: After racial justice training, some keep the conversation going

After participating in GCF's racial justice training, a small group continues the dialogue on its own, taking learnings from the programs and running with them.

City of Opportunity: Cities shaped one man’s journey from growing up poor and Black to prosperity

The experiences of urban life played a role in the groundbreaking career of Ed Rigaud in business, entrepreneurship, and sports.

Part of Kinettix' Philippines workforce.
Fast-growing local IT firm expands its international presence

Kinettix has been named to the Inc. 5000 list of the fastest-growing companies for two consecutive years.

NKY native takes over as theater director at The Carnegie

With design work at theatres in NYC, LA and locally at Memorial Hall, NKU, Falcon Theatre, and Cincinnati Chamber Opera, Tyler Gabbard is excited to continue to offer meaningful artistic experiences close to home.

City of Hope: A new mission to expand home ownership in urban neighborhoods

A well-funded not-for-profit embarks on a mission to help turn renters into homeowners and return stability to city neighborhoods.

Highland Heights life sciences employer plans to triple space and create 200 full-time jobs

New jobs created will include Ph.D.-level scientists, analytical laboratory staff, and other scientific professionals.

Jerry Peluso with a picture of his mother, Frances.
It’s the end of an era in Newport politics.

For the first time in more than three decades, the name “Peluso” is not on the Newport ballot.

Bexion’s new drug has shown promise in treating brain cancer and other cancers.
First patient dosed in Bexion cancer drug trial

The trial is being conducted at CTI Clinical Research Center in Cincinnati. The plan is to enroll 20 patients.

Our Partners

Taft Museum of Art

We want to know what's on your mind.

Close the CTA

Don't miss out!

Everything Cincinnati, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.